0001104659-20-124908.txt : 20201113 0001104659-20-124908.hdr.sgml : 20201113 20201113135031 ACCESSION NUMBER: 0001104659-20-124908 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201113 DATE AS OF CHANGE: 20201113 EFFECTIVENESS DATE: 20201113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alitair Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001654448 IRS NUMBER: 272999493 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-380521 FILM NUMBER: 201310610 BUSINESS ADDRESS: STREET 1: 55 MADISON STREET STREET 2: SUITE 400 CITY: MORRISTOWN STATE: NJ ZIP: 07960 BUSINESS PHONE: 940-391-3540 MAIL ADDRESS: STREET 1: 55 MADISON STREET STREET 2: SUITE 400 CITY: MORRISTOWN STATE: NJ ZIP: 07960 D 1 primary_doc.xml X0708 D LIVE 0001654448 Alitair Pharmaceuticals, Inc. 55 MADISON STREET SUITE 400 MORRISTOWN NJ NEW JERSEY 07960 973-984-1669 DELAWARE None None Corporation true James E. Hoyes C/O Alitair Pharmaceuticals, Inc. 55 Madison Avenue Morristown NJ NEW JERSEY 07960 Executive Officer Director Robert Casale C/O Alitair Pharmaceuticals, Inc. 55 Madison Avenue Morristown NJ NEW JERSEY 07960 Director Pharmaceuticals No Revenues 06b false 2020-10-30 false true true false 5000 31000000 35000 30965000 false 3 0 0 0 true false Alitair Pharmaceuticals, Inc. /s/ James E. Hoyes James E. Hoyes CEO 2020-11-11